agilon health (NYSE:AGL) Earns “Hold” Rating from Needham & Company LLC

agilon health (NYSE:AGL)‘s stock had its “hold” rating reiterated by research analysts at Needham & Company LLC in a note issued to investors on Wednesday,Benzinga reports.

Other equities research analysts also recently issued reports about the stock. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and lifted their price objective for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. TD Cowen reduced their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Sanford C. Bernstein boosted their price objective on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $4.03.

agilon health Stock Up 1.8 %

Shares of agilon health stock opened at $3.71 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market cap of $1.53 billion, a P/E ratio of -3.94 and a beta of 0.66. The firm’s 50 day moving average price is $2.89 and its 200-day moving average price is $3.04. agilon health has a 52-week low of $1.50 and a 52-week high of $7.73.

Insider Buying and Selling

In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 77,500 shares of company stock worth $169,600. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several hedge funds have recently made changes to their positions in AGL. Vanguard Group Inc. boosted its position in shares of agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock worth $59,114,000 after purchasing an additional 272,787 shares in the last quarter. Capital International Investors boosted its holdings in agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after buying an additional 9,346,295 shares in the last quarter. State Street Corp boosted its holdings in agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after buying an additional 215,733 shares in the last quarter. Millennium Management LLC grew its position in agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after buying an additional 4,706,357 shares during the period. Finally, Geode Capital Management LLC grew its holdings in shares of agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after acquiring an additional 35,207 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.